Neogen (NASDAQ:NEOG) Shares Down 5.5% – Should You Sell?

09 Jan 2026, 12:46 by Amy Steele · The Cerbat Gem

Neogen Corporation (NASDAQ:NEOG – Get Free Report)’s stock price traded down 5.5% during trading on Friday . The stock traded as low as $8.44 and last traded at $9.1790. 1,803,973 shares traded hands during trading, a decline of 71% from the average session volume of 6,287,906 shares. The stock had previously closed at $9.71.

Trending Headlines about Neogen

Here are the key news stories impacting Neogen this week:

Positive Sentiment: Q2 results and guidance beat — Reported revenue of $224.7M and EPS that beat consensus (company cited $0.10 vs. $0.07 consensus); company raised FY2026 revenue guidance to $845M–$855M, above Street estimates, which fueled investor optimism. MarketBeat: Q2 results & guidance
Positive Sentiment: Strong market reaction and high bullish activity — Coverage notes the stock hit a multi‑month high and retail/institutional interest spiked; unusually large call buying was reported (several thousand calls), signaling short‑term bullish positioning. Fool: Stock surge
Neutral Sentiment: Earnings call and presentation available — Management hosted the Q2 FY2026 call and posted slides/transcript for investors to assess underlying drivers and outlook. Earnings call transcript
Neutral Sentiment: Analyst coverage and targets remain mixed — Some firms have constructive ratings, but median price targets in recent public data sit below the post‑rally levels, indicating differing views on sustainable recovery. Quiver: analyst & target summary
Negative Sentiment: GAAP results and cash‑flow/headline metrics are mixed — Third‑party reporting highlights an operating loss, a GAAP net loss and a decline in operating cash flow with higher capex, which raises questions about near‑term profitability despite the non‑GAAP beat. Those fundamentals likely prompted some sellers after the big rally. Quiver: GAAP results & cash flow
Negative Sentiment: Post‑rally profit‑taking and lighter volume — After the outsized one‑day move, some investors booked gains and daily volume has been below recent averages, contributing to a pullback from intraday highs.

Wall Street Analyst Weigh In

NEOG has been the subject of several research reports. Piper Sandler set a $6.50 price target on Neogen and gave the stock a “neutral” rating in a research report on Thursday, October 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neogen in a report on Monday, December 29th. CJS Securities raised shares of Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 price target on the stock in a research note on Wednesday, December 10th. Guggenheim restated a “buy” rating and set a $12.00 price target on shares of Neogen in a research report on Friday. Finally, Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $9.50.

Read Our Latest Stock Report on Neogen

Neogen Price Performance

The stock has a market cap of $2.06 billion, a price-to-earnings ratio of -1.98 and a beta of 1.96. The company has a current ratio of 3.58, a quick ratio of 2.26 and a debt-to-equity ratio of 0.37. The company’s fifty day moving average is $6.59 and its two-hundred day moving average is $5.85.

Neogen (NASDAQ:NEOG – Get Free Report) last issued its quarterly earnings results on Thursday, January 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.03. The business had revenue of $224.69 million for the quarter, compared to analysts’ expectations of $208.50 million. Neogen had a negative net margin of 117.61% and a positive return on equity of 2.23%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.11 earnings per share. As a group, research analysts predict that Neogen Corporation will post 0.38 earnings per share for the current year.

Institutional Trading of Neogen

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NEOG. AQR Capital Management LLC lifted its holdings in shares of Neogen by 217.0% in the 1st quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock valued at $443,000 after purchasing an additional 35,878 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Neogen by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock worth $1,125,000 after buying an additional 5,638 shares during the period. Millennium Management LLC purchased a new stake in Neogen in the first quarter valued at approximately $20,761,000. Jones Financial Companies Lllp lifted its stake in Neogen by 5,687.3% in the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock valued at $290,000 after buying an additional 32,816 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Neogen by 14.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock valued at $14,553,000 after acquiring an additional 209,990 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

Neogen Company Profile

(Get Free Report)

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.